Latest Form 4 insider transactions

Robert A Bruggeworth, a Director of Skyworks Solutions, Inc., received 1,722 shares of common stock on October 12, 2026.

Janine J Mcardle, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

Brian M Krzanich, Chief Executive Officer and a Director of Cerence Inc., sold 131,715 shares of common stock on October 9, 2026 for $8.26 per share.

Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., sold 200,000 shares of common stock on October 12, 2026.

Jeffrey S. Munoz, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

Thomas Taira, President, Special Projects of Carvana Co., sold 5,597 shares of common stock on October 12, 2026 for $65.00 per share.

John C Mollenkopf, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

Liana Pogosyan, Chief Financial Officer of Xos, Inc., reported multiple transactions in common stock on September 10, 2026.

Fernando Matt Borges Martins, a Director and 10% owner of CI&T Inc, purchased 132 shares of common stock on October 9, 2026 for $3.08 per share.

Nancy Chisholm, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

Giordano Sordoni, Chief Operating Officer and a Director of Xos, Inc., reported multiple transactions in common stock on September 10, 2026.

Dakota Semler, Chief Executive Officer and a Director of Xos, Inc., reported multiple transactions in common stock on September 10, 2026.

Elizabeth F Whited, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Peter A Dea, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

Jeffrey S. Munoz, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

Thomas B Tyree Jr, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

Mark Elliott Boulding, EXEC. VP AND CLO of Ptc Therapeutics, Inc., sold 192 shares of common stock on October 9, 2026 for $64.26 per share.

Jeffrey D Rowe, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Vicky Sutil, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

W Howard Keenan Jr, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

W Howard Keenan Jr, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

ISQ Global Fund II GP LLC and 4 others reported changes in beneficial ownership of Kinetik Holdings Inc. common stock on October 8, 2026.

Jarrad Mattieu Aguirre, Chief Medical Officer of Lyell Immunopharma, Inc., sold 422 shares of common stock on October 12, 2026 for $8.63 per share.

Brooks J Klimley, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

Ellen M Pawlikowski, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Benjamin A. Hardesty, a Director of ANTERO RESOURCES Corp, received 2,019 shares of common stock on October 10, 2026.

Brenda R Schroer, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

Frederick R. Nance, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

David H Keyte, a Director of Antero Midstream Corp, received 3,408 shares of common stock on October 10, 2026.

Jacqueline C Mutschler, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.